Type III Interferons in Systemic Lupus Erythematosus-Reference-Cited by-同舟云学术

Type III Interferons in Systemic Lupus Erythematosus

Published:2017-10 Issue:7 Volume:23 Page:368-375
ISSN:1076-1608
Container-title:JCR: Journal of Clinical Rheumatology
language:en
Short-container-title:JCR: Journal of Clinical Rheumatology

Author:

Amezcua-Guerra Luis M.,Márquez-Velasco Ricardo,Chávez-Rueda Adriana K.,Castillo-Martínez Diana,Massó Felipe,Páez Araceli,Colín-Fuentes Juan,Bojalil Rafael

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Rheumatology

Reference45 articles.

1. Systemic Lupus Erythematosus

2. Mechanisms of Autoantibody Production in Systemic Lupus Erythematosus

3. Anti-DNA antibodies — quintessential biomarkers of SLE

4. Emerging therapies for systemic lupus erythematosus — Focus on targeting interferon-alpha

5. Interferon and Granulopoiesis Signatures in Systemic Lupus Erythematosus Blood

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Type 2 hypersensitivity disorders, including systemic lupus erythematosus, Sjögren’s syndrome, Graves’ disease, myasthenia gravis, immune thrombocytopenia, autoimmune haemolytic anaemia, dermatomyositis, and graft-versus-host disease, are THαβ-dominant autoimmune diseases;Virulence;2024-09-12

2. Uncoupling interferons and the interferon signature explains clinical and transcriptional subsets in SLE;Cell Reports Medicine;2024-05

3. Lupus Erythematosus and Antiphospholipid Syndrome;Rook's Textbook of Dermatology;2024-03-19

4. Prognostic role of interferon‐lambda 3 in anti‐MDA5–positive dermatomyositis‐associated ILD;Arthritis & Rheumatology;2023-12-25

5. Association between endothelin-1 and systemic lupus erythematosus: insights from a case–control study;Scientific Reports;2023-09-25